Latin America News Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.

Press releases published on September 30, 2026

Sep. 30, 2026

MEXC adds another 1,000 BTC to Guardian Fund, strengthening user protection

Indeterminate GlobeNewswire

Sep. 30, 2026

MEXC Leads SOL and DOGE Market-Price Liquidity in CoinGecko's 2026 CEX Report

Indeterminate GlobeNewswire

Sep. 30, 2026

R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia

Indeterminate GlobeNewswire

Sep. 30, 2026

EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application

Indeterminate GlobeNewswire

Sep. 30, 2026

More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research

Indeterminate GlobeNewswire

Sep. 30, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

Indeterminate GlobeNewswire

Sep. 30, 2026

Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

Indeterminate GlobeNewswire

Sep. 30, 2026

GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

Indeterminate GlobeNewswire

Sep. 30, 2026

Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress

Indeterminate GlobeNewswire

Sep. 30, 2026

Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering

Indeterminate GlobeNewswire

Sep. 30, 2026

Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa

Indeterminate GlobeNewswire

Sep. 30, 2026

GoldHaven Announces Fully Subscribed $1.0 Million Flow-Through Financing

Indeterminate GlobeNewswire